ArticleJCO oncology practice2023

Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health Records.

Letizia Polito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.